sharecast

{{ storiesRelated.title }}

Full List Of Stories
24 Jul
dl nyse new york stock exchange new york city nyc wall street wall st nasdaq markets trading finance unsplash
US close: Stocks sharply lower following Q2's first big-name tech earnings

Wall Street stocks closed sharply lower on Wednesday after investors got their first taste of Q2 big tech earnings overnight and thumbed over a number of data points.

24 Jul
dl volution group ventilation air circulation products manufacturing engineering technology logo ftse 250
Broker tips: Volution, Nexteq

Over at Berenberg, analysts hiked their target price on ventilation equipment business Volution to 600. 0p from 500. 0p on Wednesday following the group's full-year trading update.

24 Jul
dl city of london bank junction underground financial london stock exchange street pb
Director dealings: Jubilee Metals CEO raises stake

Jubilee Metals revealed on Wednesday that chief executive officer Leon Coetzer had acquired 625,000 ordinary shares in the Africa-focussed metals processor.

24 Jul
dl wall street wall st new york city new york stock exchange nyse dow jones nasdaq street sign nyc united states usa america pb
US open: Stocks lower following tech earnings, data

Wall Street stocks were firmly in the red early on Wednesday after investors got their first taste of Q2 big tech earnings overnight and thumbed over a number of data points.

24 Jul
dl tortilla mexican grill plc aim consumer discretionary travel and leisure restaurants and bars logo 20230327
Tortilla Mexican Grill warns on FY profits

Shares in fast-food restaurant chain Tortilla Mexican Grill slumped on Wednesday after the group warned that steps taken to boost profitability were taking longer than expected to bear fruit.

24 Jul
dl nyse new york stock exchange wall st street city finance dow jones nasdaq sp finance dollar dollars us usa united states of america
US pre-open: Futures lower following first batch of Q2 tech earnings

Wall Street futures were pointing to losses ahead of the bell on Wednesday after investors got their first taste of Q2 big tech earnings overnight.

24 Jul
dl learning technologies group plc aim ltg technology software and computer services software learning tech logo
Learnings Technologies H1 revenues down, EBITDA up

Digital learning specialist Learning Technologies warned on Wednesday that its core market remained "subdued" during H1 but said margin improvements helped boost earnings throughout the period.

24 Jul
dl volution group ventilation air circulation products manufacturing engineering technology logo ftse 250
Berenberg raises target price on Volution

Over at Berenberg, analysts hiked their target price on ventilation equipment business Volution to 600. 0p from 500. 0p on Wednesday following the group's full-year trading update.

24 Jul
dl lbg media aim youth digital publishing advertising technology logo
LBG Media H1 earnings more than double YOY

Digital entertainment business LBG Media said on Wednesday that both earnings and revenues had surged in the six months ended 30 June, leaving it confident of its ability to meet full-year expectations.

24 Jul
dl quixant aim gaming broadcast broadcasting technology services solutions digital provider logo
Canaccord Genuity lowers target price on Nexteq

Analysts at Canaccord Genuity lowered their target price on B2B technology group Nexteq from 300. 0p to 200. 0p on Wednesday despite "strong margins and cash", noting that destocking persisted.

24 Jul
dl corero network security plc cns technology technology software and computer services software aim logo 20230921 1457
Corero Network Security expects positive H1 EBITDA performance

Software specialist Corero Network Security expects to report a positive EBITDA performance for H1 following "strong trading" throughout the period.

24 Jul
dl shield therapeutics aim pharmaceutical medicine research development drug logo
Shield Therapeutics net sales grow in Q2, CEO stands down

Commercial-stage pharmaceutical company Shield Therapeutics said on Wednesday that total net sales had grown in Q2, driven by "robust" increases in prescriptions and higher net selling prices.